IPA appoints Samir Mehta from Torrent, Samina Hamied from Cipla as new office bearers
New Delhi: Indian Pharmaceutical Alliance (IPA) has recently announced the appointment of Mr Samir Mehta and Ms Samina Hamied as new office bearers.
Mr Samir Mehta, Chairman of Torrent Group has been appointed as President of the IPA for 2021-2023. Simultaneously, Ms Samina Hamied, Executive Vice Chairperson, Cipla will be the new Vice President.
Speaking on the new role, Mr. Mehta said, "COVID 19 has been a challenging time for the Indian pharmaceutical industry. However, the industry has risen to the challenges and ensured continuous supply of medicines to patients. The pandemic has further highlighted the significance of collaboration, access to affordable medicines and innovation to respond to the country's healthcare needs. IPA will be collaborating with stakeholders to strengthen the accessibility of medicines and help in creating an innovation ecosystem that will be beneficial to the patients."
Ms Samina Hamied is the Executive Vice-Chairperson of Cipla and represents the third generation of the founding family of Cipla.
Ms. Hamied said "Pleased to receive this opportunity to play a pivotal role in shaping the healthcare ecosystem and unlocking significant growth opportunities. I am looking forward to working collaboratively with all stakeholders of the industry to ensure sustainable, resilient and agile operations and create a positive difference in the lives of patients."
Sudarshan Jain, Secretary General, IPA, states "At this unprecedented time of COVID-19 pandemic when pharmaceutical industry is undergoing a crucial phase of its growth and development, IPA will continue to play a vital role in realising the Industry Vision 2030 of being the largest producer of medicines in the world in volume and move up the value chain with focus on research and development."
Indian Pharmaceutical Alliance (IPA) represents 23 research based national pharmaceutical companies. Collectively, IPA companies account for over 85 per cent of the private sector investment in pharmaceutical research and development. They contribute more than 80 per cent of the country's exports of drugs and pharmaceuticals and service over 57 per cent of the domestic market.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.